REVB Q2 2025 Earnings — Revelation Biosciences, Inc. Revenue & Financial Results | Market Cap Arena

REVBRevelation Biosciences, Inc.

$2M

Q2 2025 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$0

Gross Profit

-$7,220

Operating Income

-$2M

Net Income

-$2M

EPS (Diluted)

$-7.01

QoQ Revenue Growth

NaN%

Cash Flow

Operating Cash Flow

-$2M

Free Cash Flow

-$2M

Stock-Based Comp.

$873

Balance Sheet

Total Assets

$5M

Total Liabilities

$2M

Stockholders' Equity

$4M

Cash & Equivalents

$5M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$0	$0	—
Gross Profit	-$7,220	-$7,220	+0.0%
Operating Income	-$2M	-$3M	+2.4%
Net Income	-$2M	-$8M	+70.9%